Artelo Biosciences, Inc.

ARTL

$6.22

-4.60%

2026-09-03 16:00:01 EDT-$0.30

Healthcare

Biotechnology

NASDAQ

Active Trading

Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Gregory D. Gorgas	President, Chief Executive Officer, Secretary & Director	USD 876,923		1963	Active
Mark E. Spring	Chief Financial Officer, Treasurer, Principal Financial Officer & Principal Accounting Officer	USD 225,980		1959	Active
Andrew Yates	Senior Vice President & Chief Scientific Officer	—	—	—	Active
Steven D. Reich	Chief Medical Officer	—	—	1946	Active
Jason H. Baybutt	Senior Vice President of Finance	—		1972	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-06-05	2025	Gregory D. Gorgas,	President President, CEO CEO, Secretary, and Director Director and Former Former CFO CFO and Treasurer	Founder / CEO	$540.00K	$270.00K	$0	$346.53K	$0	$66.92K	$1.22M
2026-06-05	2025	Mark E. Spring,	CFO CFO and Treasurer	C-Level	$41.67K	$0	$0	$64.56K	$0	$184.31K	$290.54K
2026-06-05	2024	Gregory D. Gorgas,	President President, CEO CEO, Secretary, and Director Director and Former Former CFO CFO and Treasurer	Founder / CEO	$520.00K	$242.45K	$0	$240.02K	$0	$58.00K	$1.06M
2025-12-11	2024	Gregory D. Gorgas	President President, CEO CEO, CFO CFO, Secretary, Treasurer and Director Director	Founder / CEO	$520.00K	$242.45K	$0	$240.02K	$0	$58.00K	$1.06M
2026-06-05	2024	Mark E. Spring,	CFO CFO and Treasurer	C-Level	$0	$0	$0	$0	$0	$813	$813
2025-12-11	2023	Gregory D. Gorgas	President President, CEO CEO, CFO CFO, Secretary, Treasurer and Director Director	Founder / CEO	$485.42K	$251.20K	$0	$251.64K	$0	$5.83K	$994.10K

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of ARTL

RELATIONS

Upstream

Syngene International LtdNSE:SYNGENEWorldwide Clinical TrialsScienceMachineNEOMED InstituteAptus Clinical Ltd (now part of Catalyst Clinical Research / Worldwide Clinical Trials)AstraZeneca plcNASDAQ:AZNCatalyst Clinical ResearchKohlberg & Company (TJC)

Downstream

Potential Out-Licensing Partner (Seeking – ART27.13)

Proxies

Corbus Pharmaceuticals Holdings, Inc.NASDAQ:CRBP IGC Pharma, Inc.NYSEAMERICAN:IGCAvicanna Inc.TSX:AVCNHarmony Biosciences Holdings, Inc.NASDAQ:HRMY

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer